Harmony Biosciences Holdings (HRMY) Change in Inventory (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted Change in Inventory of -$76000.0 for Q1 2026, up 95.02% sequentially from -$1.5 million in Q4 2025, and up 90.66% YoY from -$39860.8 in Q1 2025.
Harmony Biosciences Holdings (HRMY) Change in Inventory (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Change in Inventory for 8 years, with the latest figure at -$76000.0 in Q1 2026.
- Quarterly Change in Inventory rose 90.66% year-over-year to -$76000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 309.3% YoY) and the FY2025 annual result came in at -$1.8 million, down 200.33% from the prior year.
- Change in Inventory climbed to -$76000.0 in Q1 2026 per HRMY's latest filing, from -$1.5 million in the prior quarter.
- Over five years, Change in Inventory peaked at $1.3 million in Q3 2024 and troughed at -$1.5 million in Q4 2025.
- A 5-year average of $49941.2 and a median of $165000.0 in 2022 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2024 and 2025: Change in Inventory surged 445.92% in 2024, then slumped 638.87% in 2025.
- Over 5 years, Change in Inventory stood at $397000.0 in 2022, then slumped by 30.48% to $276000.0 in 2023, then increased by 2.54% to $283000.0 in 2024, then plunged by 638.87% to -$1.5 million in 2025, then soared by 95.02% to -$76000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$76000.0, -$1.5 million, and $782000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.08 Mn |
| Jun 30, 2026 | 1.08 Mn |
| Mar 31, 2026 | -76,000.00 |
| Mar 31, 2026 | -76,000.00 |
| Dec 31, 2025 | -1.53 Mn |
| Dec 31, 2025 | -1.53 Mn |
| Sep 30, 2025 | 782,000.00 |
| Sep 30, 2025 | 782,000.00 |
| Jun 30, 2025 | -284,000.00 |
| Jun 30, 2025 | -284,000.00 |
| Mar 31, 2025 | -814,000.00 |
| Mar 31, 2025 | -814,000.00 |
| Dec 31, 2024 | 283,000.00 |
| Dec 31, 2024 | 283,000.00 |
| Sep 30, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | -214,000.00 |
| Jun 30, 2024 | -214,000.00 |
| Mar 31, 2024 | 494,000.00 |
| Mar 31, 2024 | 494,000.00 |